Lanean...
Personalized peptide vaccination for cervical cancer patients who have received prior platinum-based chemotherapy
A feasibility study was performed to evaluate the immunological efficacy and safety of a personalized peptide vaccine (PPV) for cervical cancer patients who have received platinum-based chemotherapy. A total of 24 patients with standard chemotherapy-resistant cervical cancer, including 18 recurrent...
Gorde:
| Argitaratua izan da: | Cancer Sci |
|---|---|
| Egile Nagusiak: | , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley & Sons, Ltd
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4582979/ https://ncbi.nlm.nih.gov/pubmed/26122553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12729 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|